Form 4: Nature's Sunshine CEO Kenneth Romanzi Equity Vesting

CEO Kenneth Romanzi acquired 13,118 shares of Nature's Sunshine Products following the achievement of a performance-based EBITDA milestone.

Summary

• CEO Kenneth G. Romanzi acquired 13,118 common shares upon the vesting of performance-based restricted stock units.
• The vesting was triggered by the company achieving an adjusted EBITDA milestone of $52 million over a rolling 12-month period.
• A total of 5,753 shares were withheld by the company to satisfy tax obligations related to the vesting.
• Following these transactions, the CEO holds a total of 110,246 common shares.

Sentiment

Score: 6

Explanation: StockSavvy.ai views this as a neutral-to-positive event, as it confirms the company met its stated financial performance targets, though it is a routine executive compensation disclosure.

Positives

• The company successfully achieved a significant performance milestone of $52 million in adjusted EBITDA.
• The CEO's compensation is directly aligned with company financial performance, incentivizing long-term growth.

Negatives

• The transaction resulted in a net increase of 7,365 shares for the CEO after tax withholding.

Risks

• Future vesting of the remaining half of the performance-based restricted stock units is contingent upon the passage of time (one year from the milestone achievement).

Future Outlook

The remaining half of the performance-based restricted stock units granted on November 4, 2025, is scheduled to vest one year following the achievement of the $52 million adjusted EBITDA milestone.

Management Comments

• The vesting of shares is directly tied to the company's achievement of an adjusted EBITDA milestone of $52M over a rolling 12-month period.

Industry Context

StockSavvy.ai notes that performance-based equity vesting is a standard governance practice in the consumer health and wellness sector, signaling management's confidence in meeting specific profitability targets.

Comparison to Industry Standards

• The use of rolling 12-month EBITDA targets is consistent with industry benchmarks for executive incentive plans in mid-cap consumer goods companies.
• Tax withholding via share reduction is a standard administrative procedure for equity-based compensation.

Stakeholder Impact

• Shareholders benefit from the alignment of executive incentives with the company's EBITDA growth targets.

Next Steps

• Vesting of the remaining 50% of the performance-based restricted stock units granted on November 4, 2025, expected in May 2027.

Key Dates

Keywords

Nature's Sunshine Products, NATR, Insider Transaction, Form 4, Executive Compensation, EBITDA Milestone